Form 4 Biohaven Ltd. For: Oct 28 Filed by: Coric Vlad
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Biohaven Pharma (BHVN) CEO Buys Another $400K in Stock
November 1, 2022 8:19 AM EDTBiohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 25,800 shares on 10/31/22 at $15.968.
The value of the purchase was $411,995.
Yesterday, Coric disclosed the purchase of $2.1 million in stock.
... MoreBiohaven Pharma (BHVN) CEO Buys $2.1M in Stock
October 31, 2022 8:29 AM EDTBiohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 141,930 shares on 10/28/22 at $14.8242-14.8665.
The value of the purchase was $2,105,772.
... More